Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity
Background and aims: Osteoarthritic patients treated with high doses of chondroitin sulfate (CS) have a lower incidence of coronary heart disease - but the mechanistic aspects of these beneficial effects of CS remain undefined. We examined how CS treatment affects the formation of atheroma via inter...
| Main Authors: | , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
Elsevier BV
2017
|
| Online Access: | http://hdl.handle.net/1721.1/112764 https://orcid.org/0000-0002-2009-5911 https://orcid.org/0000-0002-7832-7156 |